Laboratory quality has several connected parts: the requirements governing a facility, the design of its methods, the competence of its staff and the handling of a specimen and report. Safety also includes the people carrying out the work. A reliable instrument cannot compensate for every problem elsewhere in the process.
CLIA concerns the quality of laboratory testing
The Centers for Medicare & Medicaid Services describes regulation of human laboratory testing through the Clinical Laboratory Improvement Amendments program, or CLIA. The program covers testing used for health assessment or to diagnose, prevent or treat disease. Its objective is laboratory results that are accurate, reliable and timely.
CLIA requirements depend on the complexity of a test method. CMS explains that greater complexity brings more stringent requirements. This connects regulation with the scientific and operational demands of the work, rather than treating all methods as interchangeable.
The CLIA reference describes standards and certificates for clinical laboratory testing. Certification of a laboratory concerns the facility and its testing activities. It is a different question from the professional credentials of a person working there. The certification and licensure guide explains that distinction in the context of careers.
Test complexity is about the method and its demands
The U.S. Food and Drug Administration’s categorization guide describes waived, moderate-complexity and high-complexity tests. Its criteria include scientific knowledge, training, reagent preparation, operational steps, calibration and control materials, troubleshooting and interpretation. The category is tied to how a test is carried out, including the judgment needed to resolve problems.
For example, the guide distinguishes automatically controlled operations from steps requiring close monitoring, precise timing or extensive calculations. It also distinguishes simple maintenance from work needing specialized knowledge. The FDA criteria make the connection between a method's operation and the preparation of the people performing it explicit.
The FDA defines in vitro diagnostics as tests on samples such as blood or tissue taken from the body. Its in vitro diagnostics overview describes use in laboratories, other professional settings and some home settings. The location of testing and the complexity of the method are separate parts of understanding how it is regulated.
Quality control belongs within a managed process
Quality control reviews whether work meets defined requirements. The quality control reference describes controlled processes, performance criteria, records and staff competence as relevant factors. In laboratory work, that is a useful way to connect a measurement with the conditions under which it was produced.
The FDA's categorization criteria specifically include calibration, quality-control and proficiency-testing materials. The criteria for test systems also consider whether such materials are stable and available. Troubleshooting, equipment maintenance and independent judgment are part of the same assessment. Quality therefore depends on both routine procedures and the response when those procedures reveal a problem.
Errors can begin before the instrument starts
A 2006 paper on laboratory errors reported that the surveys it reviewed found more mistakes before and after analysis than during the analytical stage. It discussed communication and process design as contributors, including steps involving professionals outside the laboratory. The observation concerns the whole testing process rather than blame attached to a particular occupation.
A 2023 narrative review of the pre-analytical phase described the expansion of that phase to include test selection, alongside efforts to improve and standardize pre-analytical work. Its account connects sample-related processes to overall testing quality. The sample-to-result guide follows collection, processing, analysis, review and reporting as parts of that connected path.
Biosafety is a system of precautions
A biosafety level specifies containment precautions for work with biological agents. The biosafety level reference describes increasing levels of protection involving work practices, protective equipment, facility features and training. It is a description of containment arrangements, not an occupational rank.
The same reference contrasts basic hygienic precautions with more demanding containment features such as controlled airflow, sealed containers, access controls and specialized training. Its overview of containment makes clear that safety is built from interacting measures. The type of laboratory work determines which precautions are relevant.
OSHA and protection at work
OSHA’s bloodborne-pathogen overview describes employer responsibilities for an exposure-control plan. Its components include engineering and work-practice controls, protective clothing and equipment, training and medical surveillance. The focus is preventing occupational exposure through a planned workplace system.
OSHA’s laboratory overview also describes chemical, biological, physical and radioactive hazards and musculoskeletal stresses. Its laboratory standard concerns occupational exposure to hazardous chemicals in non-production laboratories; other standards cover other hazards. Safety knowledge therefore extends beyond handling biological material to equipment, chemical use and the physical organization of work.
Consumer testing and evidence
The FDA describes direct-to-consumer tests as tests marketed without the involvement of a health care provider. Its overview states that supporting evidence varies and that some tests receive FDA review while others do not. This is a description of testing arrangements and oversight, not a recommendation to obtain a test.
When it reviews these tests, the FDA considers whether a method measures its target accurately and reliably, whether the measurement predicts a state of health and whether claims are supported. The FDA’s explanation of review separates analytical validity from clinical validity. That distinction is useful across laboratory science: measuring a substance and understanding its clinical meaning are connected but different tasks.